The Patent Finder

Verona Pharma Limited

Also on record
Records under this name other than the patents Verona Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.

Back to Verona Pharma Limited

PatentTitleStatus Expires Confidence
US 6,794,391Derivatives of PYRIMIDO[6.1-A]ISOQUINOLIN-4-ONE
Term ended
Term ended Sep 26, 2021 · High confidence
Term endedTerm ended Sep 26, 2021High confidence
US 7,105,663Derivatives of Pyrimido[6,1-a]isoquinolin-4-one
now held by Verona Pharma PLC
Term ended
Term ended Sep 26, 2021 · High confidence
Term endedTerm ended Sep 26, 2021High confidence
US 7,378,424Derivatives of Pyrimido[6,1-a]isoquinolin-4-one
now held by Verona Pharma PLC
Term ended
Term ended Sep 26, 2021 · High confidence
Term endedTerm ended Sep 26, 2021High confidence
US 6,991,810Product from Starfish
Lapsed on the fee record
Ended Jan 31, 2014 · High confidence
Lapsed on the fee recordEnded Jan 31, 2014High confidence
14/342,490Treating Cough and Tussive Attacks
Abandoned
Abandoned Feb 23, 2015
AbandonedAbandoned Feb 23, 2015
17/280,452Pharmaceutical Compositions Comprising RPL554 in HFA-134A for Administration by Inhalation
Abandoned
Abandoned Apr 5, 2024
AbandonedAbandoned Apr 5, 2024
17/632,891Pharmaceutical Composition Comprising Ensifentrine
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/417,410Liquid Pharmaceutical Composition
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/417,864Ensifentrine (RPL554) for Treating Moderate Copd
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/616,878Pharmaceutical Compositions Comprising RPL554 in HFA-134A for Administration by Inhalation
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 20 records shown.
Pro members see all 20.
Pro members: see all 20 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited